drugset / Trial / NCT06592144

TESTO-TRIAL: Use of Testosterone in Critically Ill Patients

NCT06592144

Phase 4 Active not recruiting 94 enrolled Leticia Maria Defendi Barboza Marson
RandomizedParallel-groupQuadruple-blindSupportive care

Summary

The objective of this study is to evaluate whether the use of the anabolic agent testosterone cypionate in critically ill patients, compared to placebo, increases the number of ventilator-free days

Timeline

Start
2024-09-09
Primary completion
2026-08-02
Completion
2026-11-02

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Testosterone Cypionate Small molecule 200 mg Intramuscular

Indications